Clinical Trial Update: Technetium [99mTc]-H7ND in Patients With Gastrointestinal Malignancies and Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 trial of Technetium-99m H7ND in patients with gastrointestinal cancers and healthy volunteers has completed, assessing safety and early imaging feasibil…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Cancer

Drugs mentioned

• Technetium-99m H7ND (Technetium-99m H7ND)

Snippet

Sponsor: Jiaxing Pharmadax Genesis Pharmaceutical Technology Co.,Ltd. | Conditions: Solid Tumor | Phase 1 | Status: COMPLETED